Compugen Reports Second Quarter 2023 Results
Advancing enrollment in two proof-of-concept studies evaluating triple blockade of DNAM-1 axis in patients with microsatellite stable colorectal cancer and...
Source: prnewswire.com
Page 14 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Compugen Today - Breaking & Trending Today
Compugen : 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, SEPTEMBER 20, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF...
Source: marketscreener.com
Compugen (CGEN) to Release Earnings on Monday
Compugen (NASDAQ:CGEN – Get Free Report) will release its earnings data before the market opens on Monday, August 7th. Analysts expect Compugen to post earnings of ($0.13) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Compugen (NASDAQ:CGEN – Get Free Report) […]
Source: modernreaders.com
KRAS Inhibitors Market is Evolving Rapidly at a CAGR of 36% by 2032, Assesses DelveInsight
/PRNewswire/ -- DelveInsight's KRAS Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging KRAS...
Source: prnewswire.com
Compugen (NASDAQ:CGEN) Share Price Passes Above Two Hundred Day Moving Average of $0.85
Shares of Compugen Ltd. (NASDAQ:CGEN – Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.85 and traded as high as $1.17. Compugen shares last traded at $1.15, with a volume of 141,388 shares trading hands. Analysts Set New Price Targets Separately, StockNews.com […]
Source: tickerreport.com